Methods. We performed a retrospective descriptive study in our tertiary care hospital in Louisiana to describe the clinical features, Cerebrospinal fluid (CSF) findings and clinical outcomes. Patients aged >18 years admitted in our hospital between January 1, 2012 and December 31, 2017 were included. Hospital Electronic Health records were screened for diagnosis of WNND by ICD codes and positive WNV antibody testing in CSF.
Results. There were a total of 23 patients identified with positive WNV IgM or IgG in CSF. Fifteen patients were males and eight were female. The median age was 48.8 years. Six patients were diagnosed with meningitis, 12 with encephalitis, and five with meningoencephalitis. Most Common presenting symptoms were altered mental status and fever in 15 patients. Only two patients gave history of mosquito bite. Incidence was peak in the month of August, July, and September.
WNV IgG and IgM antibodies were positive in CSF in 13 patients. Four patients had only positive WNV IgM and six patients had only positive WNV IgG. The average number of days from the admission to diagnosis of infection ranged from 3 to 16 days with average of 8.9 days. CSF protein was >45 mg/dL in 12 patients and elevated white cell count (>5 mm 3 ) in 20 patients. CSF protein >100 mg/dL was seen in nine patients. Lymphocytosis was present in 10 patients. The average length of stay was 13.3 days and nine patients required ICU stay. Only one patient was not given any antibiotics. The average duration of antibiotics was 6.4 days. On 1 year follow-up, eight patients had no residual deficits, four patients had residual deficits, two patients were deceased, and nine patients were lost to follow-up.
Conclusion. WNV infection has become endemic in Southern United States especially in summer months. Identifying the infection early in its clinical course would help to avoid unnecessary antibiotics when patients present with fever and meningeal symptoms. Including WNV antibodies in CSF studies is critical in making a diagnosis.
Disclosures. All authors: No reported disclosures. Background. In Costa Rica (CR), bacterial meningitis (BM) is an important cause of morbi-mortality in the pediatric population. Pneumococcal meningitis was the leading cause of BM before 2009. PCV7 was introduced in the National Immunization Schedule (NIS) in 2009 (3 + 1 schedule) and then changed to PCV13 (2 + 1 schedule) in 2012. Our objective was to describe the epidemiology, bacteriology, clinical findings, and complications in patients with BM admitted to the only tertiary pediatric hospital in CR and compare these findings with the epidemiology of the pre-PCV era.
Epidemiology of Bacterial Meningitis in Pediatric Population
Methods. Retrospective, descriptive study of patients hospitalized with BM from January 2009 to December 2015. We described the first epidemiological study of BM after the introduction of PCV in NIS in CR.
Results. Seventy-six patients were enrolled. Forty-nine patients (64.5%) were male and the median age at admission was 18 months; 63 patients (82.8%) under 24 months of age, but 20 patients (31.7%) were under 2 months of age. Mean length of stay was 19.3 days (range 16.07-22.59). Only 13.2% patients had at least one PCV dose. S. pneumoniae was isolated in 21/76 (27.6%), followed by S. agalactiae in 20/76 (26.3%) and E. coli 13/76 (17.1%). N. meningitidis was not isolated during the study period. Only 9/21 pneumococcal isolates were typified: vaccine serotypes 5, 6B, 7F, and 14 were found in 3/9 patients (33.3%) and in 1/9 patients (11.1%) each, respectively; non-vaccine serotypes 9N, 10A, and 13 were found in 1/9 patients each. All of the CSF pneumococcal isolates were penicillin susceptible. Complications were documented in 24/76 patients (31.6%), been hypoacusia and neurological disabilities the most common. Mortality was documented in 4/76 (5.3%). The incidence of BM in the post-PCV was dramatically reduced in comparison with the pre-PCV era, with a 54.7% reduction of all causes of BM and a 46.7% reduction in pneumococcal meningitis. Letality due to pneumococcal meningitis was also reduced from 20% to 14.3%.
Conclusion. In CR, BM is an important cause of high morbidity. Pneumococcal meningitis is still the leading cause of BM in our pediatric population, but a dramatic reduction in pneumococcal meningitis was observed after the introduction of PCV's in our NIS. Mortality was lower than what is reported in industrialized countries.
Disclosures. Background. Polyradiculopathy (PRP) and encephalitis are neurologic syndromes associated with 1% of cytomegalovirus (CMV) disease among patients with advanced HIV infection. Untreated patients die within 8 weeks. This case series and literature review highlights the clinical and laboratory features integral to the prompt diagnosis and treatment of these rare but serious manifestations of CMV disease among AIDS patients.
Methods. We document CMV PRP and encephalitis in two HIV-seropositive men seen in a tertiary hospital in the Philippines. Both patients presented with bilateral leg weakness, paresthesias, hyporeflexia, and urinary retention associated with confusion and memory lapses. In the two cases described, diagnosis of CMV disease was delayed because it was not immediately entertained. Tuberculosis involving the nervous system was first ruled out.
Results. The first case was a 31-year-old male with a baseline CD4 count of 9 cells/mm 3 who presented with signs and symptoms of bilateral leg weakness and paresthesias 3 weeks after initiation of antiretrovirals (ART). CMV viremia was detected by PCR. Ganciclovir was initiated late, and he subsequently died of multiorgan failure. The second case is a 29-year-old male with a baseline CD4 count of 2 cells/mm 3. CMV DNA PCR was detected in the CSF. He died prior to initiation of anti-CMV therapy.
Conclusion. CMV-related neurologic complications are uncommon, but often fatal when appropriate anti-CMV therapy is not initiated promptly. The diagnosis of
